Moderna (MRNA) Tops Q1 EPS by $3.37, Revenue Beats

Moderna (NASDAQ: MRNA) reported Q1 EPS of $8.58, $3.37 better than the analyst estimate of $5.21. Revenue for the quarter came in at $6.1 billion versus the consensus estimate of $4.62 billion.

For earnings history and earnings-related data on Moderna (MRNA) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Moderna (MRNA) PT Raised to $120 at Goldman Sachs
• Active options: MRNA AMD AVGO PLTR GOOGL NFLX PFE SOFI NBIS COIN